Grading strength of recommendations and quality of evidence in clinical guidelines -: Report from an American College of Chest Physicians task force

被引:899
作者
Guyatt, G
Gutterman, D
Baumann, MH
Addrizzo-Harris, D
Hylek, EM
Phillips, B
Raskob, G
Lewis, SZ
Schünemann, H
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[3] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[4] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA
[5] NYU, Sch Med, New York, NY USA
[6] Boston Univ, Sch Med, Dept Med, Res Unit,Sect Gen Internal Med, Boston, MA 02118 USA
[7] Univ Kentucky, Coll Med, Lexington, KY USA
[8] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA
[9] Amer Coll Chest Phys, Northbrook, IL USA
[10] Italian Natl Canc Inst, Dept Clin Epidemiol, Rome, Italy
关键词
grading recommendations; grading system; methodology;
D O I
10.1378/chest.129.1.174
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
While grading the strength of recommendations and the quality of underlying evidence enhances the usefulness of clinical guidelines, the profusion of guideline grading systems undermines the value of the grading exercise. An American College of Chest Physicians (ACCP) task force formulated the criteria for a grading system to be utilized in all ACCP guidelines that included simplicity and transparency, explicitness of methodology, and consistency with current methodological approaches to the grading process. The working group examined currently available systems, and ultimately modified an approach formulated by the international GRADE group. The grading scheme classifies recommendations as strong (grade 1) or weak (grade 2), according to the balance among benefits, risks, burdens, and possibly, cost, and tire degree of confidence in estimates of benefits, risks, and burdens. The system classifies quality of evidence as high (grade A), moderate (grade B), or low (grade C) according to factors that include the study, design, the consistency of the results, and the directness of the evidence. For all future ACCP guidelines, The College has adopted a simple, transparent approach to grading recommendations that is consistent with current developments in the field. The trend toward uniformity of approaches to grading will enhance the usefulness of practice guidelines for clinicians.
引用
收藏
页码:174 / 181
页数:8
相关论文
共 19 条
  • [1] [Anonymous], 2003, COCHRANE DATABASE SY
  • [2] Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
  • [3] LONG-TERM RESULTS OF VALVE-REPLACEMENT WITH THE ST-JUDE MEDICAL PROSTHESIS
    BAUDET, EM
    PUEL, V
    MCBRIDE, JT
    GRIMAUD, JP
    ROQUES, F
    CLERC, F
    ROQUES, X
    LABORDE, N
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (05) : 858 - 870
  • [4] Antithrombotic therapy for venous thromboembolic disease
    Büller, HR
    Agnelli, G
    Hull, RD
    Hyers, TA
    Prins, AH
    Raskob, GE
    [J]. CHEST, 2004, 126 (03) : 401S - 428S
  • [5] Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis - A clinical outcome study
    Chong, BH
    Gallus, AS
    Cade, JF
    Magnani, H
    Manoharan, A
    Oldmeadow, M
    Arthur, C
    Rickard, K
    Gallo, J
    Lloyd, J
    Seshadri, P
    Chesterman, CN
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) : 1170 - 1175
  • [6] Antithrombotic therapy in peripheral arterial occlusive disease
    Clagett, GP
    Sobel, M
    Jackson, MR
    Lip, GYH
    Tangelder, M
    Verhaeghe, R
    [J]. CHEST, 2004, 126 (03) : 609S - 626S
  • [7] Collins R, 1996, BMJ-BRIT MED J, V313, P652
  • [8] Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis
    de Bruijn, SFTM
    Stam, J
    [J]. STROKE, 1999, 30 (03) : 484 - 488
  • [9] Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399
  • [10] Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study
    Devereaux, PJ
    Anderson, DR
    Gardner, MJ
    Putnam, W
    Flowerdew, GJ
    Brownell, BF
    Nagpal, S
    Cox, JL
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7323): : 1218 - 1221